Newsletter Subscription


Monday, March 27, 2017


Implant Sciences QS-B220 Trace Detection System Gains Further Traction in the European Airport Security Market

Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today announced that it has sold its Quantum Sniffer™ QS-B220 desktop explosives and drugs trace detector to a new customer in Europe. The unit will be used for airport security at a major international airport in Europe.

"Designed to meet the requirements of aviation security professionals, our desktop trace detector is gaining increasing acceptance and traction in global markets. As we continue to grow our distribution channel, we look forward to demonstrating its advantages in increasing numbers of procurements," stated Implant Sciences' President and CEO, Glenn D. Bolduc.


Related Research on ASDReports.com:
Drone Payload Market - Global Forecast to 2021

"The QS-B220 provides an effective method for screening passengers without concerns about radiation and privacy. This and the ability to adapt the easy-to-use touch-screen interface to the local language were important factors in Implant Sciences winning this order from a new customer through a new distributor," added Dr. Darryl Jones, Implant Sciences' Vice President of Sales and Marketing.

Source : Implant Sciences Corp.

Published on ASDNews: Dec 10, 2012

 

Unmanned Maritime Systems Technology Conference

May 24 - 25, 2017 - London, United Kingdom

Register More info


US Export Controls on Non-US Transactions Seminar

May 15 - 18, 2017 - London, United Kingdom

Register More info


Air Mission Planning and Support 2017 Conference

Apr 5 - 6, 2017 - London, United Kingdom

Register More info


© 2004-2017 • ASDNews • be the first to know • contact usterms & conditionsprivacy policyadvertisingfaqs

zpsk